VIVE Stock Price Increases Over 3% Pre-Market: Why It Happened

VIVE Stock Price Increases Over 3% Pre-Market: Why It Happened
  • The stock price of Viveve Medical Inc (NASDAQ: VIVE) increased by over 3% pre-market. This is why it happened.

The stock price of Viveve Medical Inc (NASDAQ: VIVE) – a medical technology company focused on women’s intimate health – increased by over 3% pre-market. Investors are responding positively to Viveve Medical announcing that the Canadian Intellectual Property Office (CIPO) recently issued Canadian Patent No. 3028905 for Viveve’s dual-energy technology device and method. And the awarded patent further strengthens the Company’s intellectual property portfolio.


KEY QUOTE:


“We are pleased with the issuance of the Canadian patent for our dual-energy device. The addition of this newest patent strengthens our intellectual property portfolio, which was recently expanded by a U.S. patent, two Asia Pacific patents in South Korea and Taiwan, respectively, and a U.S. stress urinary incontinence (SUI) patent issued in the fall of 2020. We look forward to continuing to advance our global clinical development and commercialization strategy supported by our strong intellectual property estate.”


—Scott Durbin, Viveve’s chief executive officer


Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.